Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

06 Apr 20264 min read0 viewsINTERVENTIONAL Trial

GIST

RECRUITING · INTERVENTIONAL · TREATMENT study · Acute Myeloid Leukemia · Phase 3 · Enrollment 875 · Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Oncology on 06 Apr 2026. The item focuses on Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML). Open the detail page to review the full original feed content.